Skip to main content
Clinical Trials/NCT05953116
NCT05953116CompletedNot Applicable

Managing the Nutritional Needs of Older Filipino With Due Attention to Protein Nutrition and Functional Health (ManoPo) Study

Food and Nutrition Research Institute, Philippines2 sites in 1 country68 target enrollmentStarted: September 4, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
68
Locations
2
Primary Endpoint
Change in muscle strength, as measured by grip strength and leg strength (Jamar, MicroFET)

Study Overview

Brief Summary

The study aims to determine the effect of protein nutrition and exercise on the body composition and functional capacity of Filipino older adults.

Detailed Description

The objective of the study is to determine the effects of nutrition supplementation and exercise intervention on the main indicators of sarcopenia in older adults such as body composition (fat mass and lean mass), muscle strength (leg and handgrip), and physical performance.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Masking Description

The trial participants and researchers will be blinded during the conduct of the 12-week intervention. An independent third party will handle randomization and allocation of participants to either intervention group (DOST-FNRI protein drink + physical activity) or placebo group (placebo product + physical activity), while trying to ensure a balanced sex distribution between the groups.

The intervention group will receive a protein-containing product which shall meet the target of 30g of protein per day of supplementation. Meanwhile, the placebo group will receive an isocaloric product (similar caloric value but with minimal to no protein content). Both products will have similar packaging, appearance, taste, and flavoring. A unique serial number only known by the independent third party will be used to differentiate between the two products. Unblinding of trial participants will be done after data analysis of a locked dataset.

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pre-sarcopenia/pre-frail
  • Aged 60 years old and above, male or female
  • Free-living in the community, ambulatory
  • Able to respond to food recall/interview as self-declared
  • Normal cardiac function as measured by resting ECG

Exclusion Criteria

  • Bed ridden, unable to perform exercise independently
  • Presence of serious medical condition (i.e. cancer, existing fracture)
  • Presence of unmanaged hypertension and/or type 2 diabetes or upon assessment of physician
  • Renal Problem
  • Under controlled or medically-supervised diet not flexible to include the intervention agent
  • Allergic to any ingredients in the nutrition supplementation

Arms & Interventions

Intervention Group

Active Comparator

A protein product (combination of whey protein and plant-derived protein) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.

Intervention: Nutrition supplementation (Dietary Supplement)

Intervention Group

Active Comparator

A protein product (combination of whey protein and plant-derived protein) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.

Intervention: Exercise (Other)

Placebo Group

Placebo Comparator

An isocaloric product (made with maltodextrin) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.

Intervention: Nutrition supplementation (Dietary Supplement)

Placebo Group

Placebo Comparator

An isocaloric product (made with maltodextrin) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.

Intervention: Exercise (Other)

Outcomes

Primary Outcomes

Change in muscle strength, as measured by grip strength and leg strength (Jamar, MicroFET)

Time Frame: Baseline, Midline (6 weeks), Endline (12 weeks)

Handgrip strength is measured using a hydraulic hand dynamometer through maximum exertion of grip force (in kilograms). Leg strength is measured using a hand-held dynamometer. Participant will use strongest leg force to push against the resistance brought upon by the researcher while holding the measuring device.

Change in physical performance, as measured by timed up-and-go test

Time Frame: Baseline, Midline (6 weeks), Endline (12 weeks)

Faster time duration to complete the test indicate lesser risk for falls

Change in physical performance, as measured by short physical performance battery

Time Frame: Baseline, Midline (6 weeks), Endline (12 weeks)

Score ranges from 0 to 12 with a higher score indicating better functionality

Change in physical performance, as measured by 10-meter walk test

Time Frame: Baseline, Midline (6 weeks), Endline (12 weeks)

Faster walking speed (in meters per second) indicate better functionality

Change in muscle mass, as measured by dual-energy x-ray absorptiometry (DXA)

Time Frame: Baseline, Midline (6 weeks), Endline (12 weeks)

Measurement of appendicular skeletal muscle mass index (ASMI) by dividing total muscle mass (kg) of appendages with height in meters squared

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Food and Nutrition Research Institute, Philippines
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Robby Carlo A. Tan

Senior Science Research Specialist

Food and Nutrition Research Institute, Philippines

Study Sites (2)

Loading locations...

Similar Trials